Eli Lilly has partnered with Nvidia to develop a powerful supercomputer aimed at accelerating drug discovery. The supercomputer will leverage AI capabilities to identify new molecules and reduce the lengthy drug development process, all while running on renewable energy within Lilly's facilities.